The hospital Filippo del Ponte is a hospital of Varese, Italy. From November 2011 hosts the activities of the Maternal Infant of the Presidium of Varese. It is part of the Azienda Ospedaliera Ospedale di Circolo e Fondazione Macchi.

During the past decade, Ospedale F. Del Ponte conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale F. Del Ponte" #1 sponsor was "Ospedale di Circolo - Fondazione Macchi" with 3 trials, followed by "National Cancer Institute, Naples" with 2 trials sponsored, "Università degli Studi dell'Insubria" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Fondazione Poliambulanza Istituto Ospedaliero" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale F. Del Ponte" #1 collaborator was "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 1 trials as a collaborator, "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 1 trials as a collaborator, "Hospital San Pietro Fatebenefratelli" with 1 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator and "Ospedale F. Del Ponte, Varese" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale F. Del Ponte" are "Music Therapy" (3 trials), "Ovarian Cancer" (2 trials), "Breastfeeding Mothers" (1 trials), "Endometrioma" (1 trials) and "Low-Lying; Placenta, Hemorrhage, Complicating Delivery" (1 trials). Many other conditions were trialed in "Ospedale F. Del Ponte" in a lesser frequency.

Most popular intervention types in "Ospedale F. Del Ponte" are "Drug" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "Lasmiditan" (1 trials) and "Medin-cno" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale F. Del Ponte" are 6 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale F. Del Ponte". 2 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ospedale F. Del Ponte, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale F. Del Ponte, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".